These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37872650)

  • 41. Intractable bleeding from the renal pelvis in a patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
    Qvigstad LF; Grøtta OJ; Hammarström C; Baco E
    Scand J Urol; 2020 Oct; 54(5):449-451. PubMed ID: 32720548
    [No Abstract]   [Full Text] [Related]  

  • 42. The natural history of epistaxis in hereditary hemorrhagic telangiectasia.
    AAssar OS; Friedman CM; White RI
    Laryngoscope; 1991 Sep; 101(9):977-80. PubMed ID: 1886446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Saba HI; Morelli GA; Logrono LA
    N Engl J Med; 1994 Jun; 330(25):1789-90. PubMed ID: 8190155
    [No Abstract]   [Full Text] [Related]  

  • 44. Amniotic graft in the management of severe epistaxis due to hereditary haemorrhagic telangiectasia.
    Laurian N; Kalmanovitch M; Shimberg R
    J Laryngol Otol; 1979 Jun; 93(6):589-95. PubMed ID: 469391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hereditary hemorrhagic telangiectasia with liver cirrhosis: a case report.
    Xu L; Xu F; Wang Q; Ke X
    BMC Gastroenterol; 2021 Sep; 21(1):343. PubMed ID: 34488642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia.
    Kovacs-Sipos E; Holzmann D; Scherer T; Soyka MB
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28652319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States.
    Brinjikji W; Wood CP; Lanzino G; Cloft HJ; Misra S; Kallmes DF; Kamath P; Pruthi RK; Krowka MJ; Swanson KL; Iyer VN
    Ann Am Thorac Soc; 2016 Sep; 13(9):1505-11. PubMed ID: 27387823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purpose-built septal splints for control of hereditary haemorrhagic telangiectasia related epistaxis: A prospective study.
    Brahmabhatt P; Mankunda Puttasiddaiah P; Hollisey-Mclean S; Bruce Whittet H
    Clin Otolaryngol; 2021 Jul; 46(4):911-914. PubMed ID: 33735539
    [No Abstract]   [Full Text] [Related]  

  • 50. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
    Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia.
    Pagella F; Semino L; Olivieri C; Corno S; Dore R; Draghi F; Lanzarini L; Vespro V; Buscarini E; Danesino C
    Am J Rhinol; 2006; 20(4):421-5. PubMed ID: 16955772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent epistaxes in hereditary haemorrhagic telangiectasia.
    Lim SM; Lane RJ
    J R Soc Med; 1997 May; 90(5):271-3. PubMed ID: 9204024
    [No Abstract]   [Full Text] [Related]  

  • 54. Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
    Huemer F; Dejaco M; Grabmer C; Melchardt T; Neureiter D; Mayer G; Egle A; Greil R; Weiss L
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):141-144. PubMed ID: 27878613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of Young's procedure in hereditary haemorrhagic telangiectasia.
    Oozeer NB; Bingham BJ
    J Laryngol Otol; 2012 Nov; 126(11):1169-71. PubMed ID: 22932648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation?
    Muller YD; Oppliger R; Breguet R; Meyer P; Rubbia-Brandt L; Petignat PA; Harr T; Dayer E; Seebach JD
    Liver Int; 2016 Dec; 36(12):1735-1740. PubMed ID: 27864873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
    Vaiman M; Martinovich U; Eviatar E; Kessler A; Segal S
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):359-63. PubMed ID: 15166924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management.
    Chin CJ; Rotenberg BW; Witterick IJ
    J Otolaryngol Head Neck Surg; 2016 Jan; 45():3. PubMed ID: 26754744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.
    Pagella F; Pusateri A; Maiorano E; Spinozzi G; Ugolini S; Lizzio R; Mirabella R; Tinelli C; Olivieri C; Matti E
    Acta Otorhinolaryngol Ital; 2021 Feb; 41(1):59-68. PubMed ID: 33746224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of consciousness, encephalopathy and hereditary haemorrhagic telangiectasia.
    Gentry R; Tokala A; Wood H
    Br J Hosp Med (Lond); 2021 Nov; 82(11):1-3. PubMed ID: 34817264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.